Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

European Medicines Agency 

EMA draws up plans to move MHRA work

Which national agencies take on which elements of the work will be revealed early next year, the European Medicines Agency (EMA) decided at its meeting on 13/14 December 2017.

EMA building

Source: Shutterstock.com

Plans are being drawn up to redistribute the European work of the UK’s medicines safety watchdog in the run up to Brexit. Which national agencies take on which elements of the work will be revealed early next year, the European Medicines Agency decided at its meeting on 13/14 December 2017.

Plans are being drawn up to redistribute the European work of the UK’s medicines safety watchdog in the run up to Brexit.

European Union (EU) business currently carried out by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the Veterinary Medicines Directorate will be shared among the EU’s national drug regulatory agencies, it has been announced.

Which national agencies take on which elements of the work will be revealed early next year, the European Medicines Agency (EMA) decided at its meeting on 13 and 14 December 2017.

A spokesperson for the EMA described the EU network of medicines regulatory agencies as “a very strong and flexible system that is able to adapt to changes as necessary without putting at risk the quality of its work”.

Also following its December meeting, the EMA said that preparing for the withdrawal of the UK from the EU will impact on its work in the coming year. It expects to maintain its core activities in 2018 —which includes deciding drug marketing authorisations — but predicts some other work will have to be “temporarily reduced” or “suspended.”

The EMA will move into temporary offices when it vacates its current home in London’s Canary Wharf and relocates to Amsterdam as its new purpose built headquarters is not expected to be completed until November 2019.

Meanwhile the agency is moving forward with the development of its EU-wide clinical trial portal and data base — which will support the needs of EU clinical research, and which it describes as “the most ambitious IT development project…required by the EU pharmaceutical legislation”.

It has tested a partially completed version of the system and, following feedback, has fixed bugs and is working on suggested improvements.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20204164

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Introduction to Clinical Pharmaceutics (An)

    Introduction to Clinical Pharmaceutics (An)

    This unique textbook covers the role of basic pharmaceutics in clinical outcomes and in explaining the behaviour of medicines in the body.

    £27.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • EMA building

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.